Target intelligence / Profile preview

Zinc finger CCCH-type containing 12A (ZC3H12A)

Target
ZC3H12A
Molecular classification
Enzyme (endoribonuclease), Zinc finger protein (CCCH-type), RNA-binding protein
01

Overview

Zinc finger CCCH-type containing 12A, most commonly known as Regnase-1 or MCPIP-1 (gene: ZC3H12A), is a CCCH-type zinc finger protein that functions as an endoribonuclease and plays a crucial role in the post-transcriptional regulation of inflammatory responses[1][2][5]. It degrades specific mRNAs (notably those encoding inflammatory cytokines such as IL-6 and IL-12b) by recognizing stem-loop structures in their 3’ untranslated regions, thereby preventing excessive or chronic inflammation[1]. The activity of Regnase-1 is tightly regulated by post-translational modifications, cytoplasmic-nuclear shuttling, and interaction with regulatory proteins such as 14-3-3 and βTRCP, which control its activity and stability[1]. Mice deficient in Zc3h12a exhibit heightened inflammatory responses and autoimmunity, underscoring its significance as a negative regulator of immune activation[1]. While ZC3H12A is clearly implicated in the control of inflammation and immune homeostasis and is an attractive therapeutic target, there are currently no approved drugs that directly target this protein[1][5].

Other names
Regnase-1MCPIP-1Mcpip1
02

Biological functions

Regulation of inflammationmRNA degradationImmune responseCell differentiationApoptosis
03

Disease associations

InflammationAutoimmune diseaseInfectionOther (including possible links to ulcerative colitis and osteoarthritis)
04

Safety considerations

Potential safety concerns of modulating Regnase-1 stem from impaired immune regulation leading to either increased susceptibility to infection or autoimmunity

Beyond the preview

Go deeper on Zinc finger CCCH-type containing 12A (ZC3H12A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zinc finger CCCH-type containing 12A (ZC3H12A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call